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Type II lumbar endoleaks: Hemodynamic
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scanning and influence on aneurysm enlargement
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Objective: The objective of this study was to differentiate type II lumbar endoleaks on the basis of dynamic features
identified by contrast-enhanced ultrasound scanning (CUS) and to evaluate the role of this differentiation in detecting
abdominal aortic aneurysm (AAA) enlargement >1 mL/mo.
Methods: Eighteen male patients (mean age, 71.8 years) with type II lumbar endoleak suspected at CUS underwent
computed tomography angiography (CTA) and digital subtraction angiography (DSA). On CTA, AAA volumes and
endoleak visualization and volumewere assessed. At CUS, performed after a bolus of 1.5 to 2.4mL of a second generation
blood pool contrast agent, the following parameters were evaluated: presence of contrast material within the aneurysmal
sac (endoleak), delay of endoleak detection (wash-in) and disappearance (washout) from the beginning of contrast
injection, visualization of inflow and outflow vessels, and presence of cavity filling. Statistical analysis was performed
regarding endoleak features at CUS, endoleak detection at CTA, and rate of AAA enlargement.
Results:DSA confirmed all the endoleaks.Mean standard deviation wash-in and washout times were 121.9 132.6 and
337.2  193.7 seconds, respectively; a significant relation was observed between these two parameters (P < .01, analysis
of variance). By Youden plots, endoleaks were classified as hyperdynamic when wash-in was <100 seconds (n  10,
55.5%) and/or washout was<520 seconds (n 13, 72.2%). A slower washout was associated with nonvisualized outflow
(66.7%) and/or inflow arteries (66.7%) (P < .05). Eight endoleaks (44.4%) were missed at CTA; it occurred in
hypodynamic endoleaks, absence of detectable inflow or outflow vessels, and absence of cavity filling at CUS (P < .05).
Overall mean AAA volume increase rate was 1.1  1.7 mL/mo. By multiple logistic regression model, the washout time
>520 seconds was the only independent predictor of AAA volume increase >1 mL/mo (8 patients, 44.4%).
Conclusion: Type II lumbar endoleaks show different hemodynamic features at CUS, which might influence the rate of
aneurysm enlargement, addressing the need for treatment. (J Vasc Surg 2005;41:10-8.)Endoleaks are defined as persistent blood flow into the
aneurysm sac and outside the graft lumen and represent the
most frequent complication after endovascular aneurysm
repair (EVAR). They might be associated with aneurysm
enlargement and possible rupture.1 The reported incidence
of endoleaks ranges from 10% to 45%, and lifelong surveil-
lance is required for their early detection and manage-
ment.2-5
Computed tomography angiography (CTA) represents
the actual gold standard in the detection of endoleaks, in
particular when both the arterial and the venous phases are
acquired,6,7 although the role of magnetic resonance an-
giography (MRA), duplex ultrasound scanning (US), and,
more recently, contrast-enhanced US (CUS) has been in-
vestigated.8-13
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10Endoleaks are classified according to their origin, which
can be directly related to stent-graft complications (types I,
III, and IV) or to retrograde flow from aortic collateral
vessels (type II).14,15 The presence of aneurysm enlarge-
ment without any evident complication has also been de-
scribed and defined as endotension or type V en-
doleak.16,17
Type II endoleaks have been reported to be the most
common type of leakage.2 Recent studies have demon-
strated that they might present different hemodynamic
features, and that differentiation might have a role in their
management and treatment.11,18
The purpose of our study was to differentiate type II
lumbar endoleaks on the basis of specific dynamic features
identified by CUS and to evaluate the capability of this
differentiation in identifying abdominal aortic aneurysm
(AAA) enlargement 1 mL/mo.
MATERIALS AND METHODS
Patients and overall study design. Our study was
approved by our Institutional Review Board, and informed
written consent was obtained in all cases.
From February 2002 to March 2004, 39 consecutive,
randomly selected patients with abdominal aortic stent-
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Genoa, Italy) at completion of a duplex US examination.
Among this series, 18 male patients (mean age, 71.8 7.8
years; range, 52 to 83 years) exhibited CUS findings sug-
gestive for a type II lumbar endoleak and therefore entered
the study. Several types of stent-graft were implanted in this
series (Table I), and in 8 of 18 cases preprocedural hypo-
gastric embolization was performed to allow deployment of
an external iliac cuff.
After endovascular aneurysm repair (EVAR), all pa-
tients underwent CTA (LightSpeedPlus; GE Medical Sys-
tems, Milwaukee, Wis) at 7-day, 6- and 12-month follow-
up, and annually thereafter. In patients with detected
endoleak, examinations were performed every 3 to 6
months. After CUS, all patients underwent digital subtrac-
tion angiography (DSA) (Multistar; Siemens, Erlangen,
Germany).
CTA protocol, post-processing and evaluation.
CTA was performed from the celiac artery to the common
femoral arteries, both before and after intravenous contrast
administration (Visipaque 320; Nycomed, Oslo, Norway)
at the dose of 120 mL with a flow-rate of 3 mL/s by using
the following parameters: HighSpeed mode capability;
gantry rotation time, 0.5 to 0.6 second; table speed, 7.5
mm per rotation; collimation, 2.5 mm; and reconstruction
section thickness, 1.2 mm. Both the arterial phase and a
delayed phase were acquired. Scan delay ranged between
20 and 40 seconds, according to the patient circulation
time, determined by an automated bolus time test (Smart-
Prep; GE Medical Systems) by using 25 mL of iodinated
contrast medium. Scans obtained during the venous phase
were acquired with the same parameters, 80 seconds after
contrast material injection.
Images were processed with a dedicated software pack-
age at an independent workstation (Advantage Windows
4.1; Sun Microsystems, Mountain View, Calif) to generate
multiplanar reformations (MPRs), maximum intensity pro-
jections (MIPs), and volume renderings (VRs).
On CTA, volumes were obtained through a semiauto-
matic segmentation process by using the summation of area
technique. The region-of-interest was drawn manually at
the interface of the outer aortic wall and the extra-aortic
tissues at 5 to 10 different levels throughout the aorta from
the lowest renal artery to the aortic bifurcation. Then the
system automatically determined the boundaries around a
class of similar voxel intensity values in the remaining
sections, and aneurysm sac volume was calculated.19 Pres-
ence and origin of endoleaks were recorded, and endoleak
volume was calculated on the venous acquisitions, with the
same modality described for AAA volume. Post-processing
and volume assessment was retrospectively performed by a
single expert radiologist (I.B., 5 years of experience in CTA
and post-processing) blinded to the CUS findings. Each
measurement was performed twice (coefficient of variation
for AAA volumes, 1.74%), and the mean value of the two
measures was obtained and used for the study.
In addition, CTA images were reviewed by consensus
by one of several authors (R.C., P.P., C.V., 10 to 15 yearsof experience in CTA) blinded to the volume measure-
ments to identify presence of endoleak (defined by contrast
enhancement within the sac and outside the stent-graft
lumen) and of other complications (such as stent-graft
migration or disconnection).
Contrast-enhanced US and evaluation. CUS was
performed by one radiologist (V.N., 4 years of experience
with CUS) blinded to CTA results, after a bolus injection of
a second generation blood pool contrast agent (Sonovue;
Bracco, Milan, Italy), consisting in stabilized microbubbles
of sulfur hexafluoride gas, administered into an antecubital
vein at the dose of 1.5 to 2.4 mL, followed by a flush of
5-mL saline solution. At the time this study was carried out,
no published data were available regarding the optimal
dose of contrast material for vascular examinations with
CUS, particularly in the follow-up of stent-grafts. At the
beginning of our experience, we performed CUS with a
bolus of 1.5 mL; afterwards, the bolus was raised up to 2.4
mL, as package insert recommended, to ensure endoleak
visualization in all patients. In the present series, the
2.4-mL bolus was injected in the last six patients. The
contrast-enhanced sonographic study was performedwith a
continuous low Mechanical Index (0.01 to 0.04) real-time
tissue harmonic imaging (Contrast Tuned Imaging; Esaote
Biomedica). The entire aorta was scanned in the longitudi-
nal and transverse planes from the diaphragm to below the
iliac limb attachment sites. Scanning was maintained for 10
minutes after contrast administration, according to the
pharmaceutical indications, setting at 11 minutes the max-
imum circulation time of the contrast agent. The entire
examination was tape-recorded to allow later review.
The following parameters were assessed: presence of
endoleak (defined as contrast enhancement within the an-
eurysm sac), endoleak wash-in (time between beginning of
Table I. Patients’ demographic and procedural data
Patient
no.
Age
(y) EF (%)
Initial
diameter
(mm) Stent-graft
Endoleak
diagnosis
Hypogastric
embolization
1 78 55 45 Excluder Early No
2 73 52.7 56 AneuRx Early Yes
3 70 58.8 75 Excluder Late Yes
4 77 29.4 59 AneuRx Early Yes
5 66 50 74 AneuRx Late No
6 61 55.7 52 Excluder Early Yes
7 75 60 46 Excluder Early Yes
8 78 55 47 Talent Late No
9 66 52 63 Excluder Late No
10 78 55 47 Talent Late No
11 61 38.8 60 AneuRx Late Yes
12 83 48.6 88 Zenith Late No
13 74 54 45 AneuRx Late No
14 52 56 55 Endologix Early No
15 73 52.7 56 AneuRx Early Yes
16 74 60 47 Endologix Late No
17 78 55 47 Talent Late No
18 75 52.5 58 Talent Late Yes
EF, Cardiac ejection fraction.contrast material injection and contrast visualization within
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contrast material injection and disappearance of all contrast
from the sac), and visualization of inflow and outflow
vessels. Moreover, the contrast enhancement was described
either as “cavity filling” (defined as contrast concentration
into a pseudocavity within the sac) or as simple spreading of
contrast within the sac.
DSA and evaluation. DSA was performed after CUS
and CTA in the angiographic suite by four experienced
interventional radiologists (I.B., P.P., R.C., C.V., 5 to 25
years of experience with angiography) aware of the findings
of previous examinations. A transfemoral arterial percuta-
neous access was used under local anesthesia. Aortography
was obtained by using a 5F pigtail catheter, positioned
above the proximal stent-graft attachment, with a bolus of
40 mL iodinated contrast medium (Visipaque 320). Then
selective angiographies of the internal iliac and superior
mesenteric arteries were performed according to the aorto-
graphic findings by using the proper shaped catheter. Im-
ages were evaluated by consensus to assess presence of
endoleak (visualized as spreading of contrast material out-
side the stent-graft) and to identify its origin (from the
aortic branches or stent-graft disconnections).
Statistical analysis.Descriptive statistics (proportions,
means, standard deviations [SDs], medians) were calcu-
lated for patient characteristics and numeric continuous
data. The 2, Pearson, and Fisher exact tests were used for
categorical data, whereas continuous data were evaluated
by bivariate fit, one-way analysis of variance, and Student t
test. A Pvalue .05 was considered statistically significant.
Analysis was performed to identify possible factors re-
lated with (1) endoleak dynamic features at CUS, (2)
endoleak visualization at CTA, and (3) rate of AAA volume
enlargement per month.
Endoleak dynamic features were tested against the fol-
lowing parameters: patient age, cardiac ejection fraction,
preprocedural hypogastric embolization, stent-graft type,
preprocedural AAA maximum diameter (calculated on
CTA on the plane perpendicular to the aortic centerline
length), early or late endoleak (detected less or more than
30 days after EVAR), outflow arteries at DSA, endoleak
features at CTA (visualization and volume), and amount of
contrast material administered at CUS. CUS detection of
inflow and outflow vessels and identification of cavity filling
were tested against wash-in and washout times.
Endoleak detection at CTA was analyzed in relation
with the following parameters: patient age, preprocedural
hypogastric embolization, stent-graft type, preprocedural
AAA maximum diameter, early or late endoleak, outflow
artery at DSA, and endoleak features at CUS.
The rate of AAA increase was expressed in mL/mo,
obtained by subtracting the AAA volumes calculated at the
last two consecutive CTA examinations, divided by the
number of months elapsing between examinations. A rate
of enlargement 1 mL/mo was arbitrarily selected to
define a significant volume increase and was tested against
patient age, duration of follow-up after EVAR, preproce-
dural hypogastric embolization, stent-graft type, preproce-dural AAA maximum diameter, early or late endoleak,
outflow artery at DSA, and endoleak features at CTA and
CUS.
By Youden plots (a graphic method able to determine a
value to optimize specificity and sensitivity of the test
measurement, it is similar to the Receiver Operating Char-
acteristic (ROC) curve but not influenced by the prevalence
of an event in the studied population, which makes it
suitable for low number of patients), cutoff values of
wash-in and washout times were set to identify rate of AAA
enlargement 1 mL/mo, and their sensitivity, specificity,
positive (PPV) and negative predictive values (NPV), and
accuracy were calculated.
A multiple logistic regression analysis was performed to
identify independent predictors of AAA enlargement 1
mL/mo.
RESULTS
Demographic data, CTA, DSA, and CUS findings are
extensively reported in Tables I to III. No adverse reactions
were observed after ultrasound contrast material adminis-
tration. Endoleaks were detected 1 to 36 months after
EVAR (mean  SD, 19  16 months; median, 24
months); seven endoleaks were diagnosed within the first
month of follow-up, whereas the remaining cases were late
endoleaks. In all patients, DSA excluded the presence of a
type I endoleak. A type II endoleak was clearly demon-
strated in 14 cases, with visualization of the lumbar arterial
inflow. In the remaining four cases (numbers 12, 13, 14,
18), DSA did not depict evident concentration of contrast
material within the thrombus; however, it demonstrated
complex hypogastric collateral pathways feeding multiple
tiny lumbar arteries afferent to the aneurysm sac.
In 9 of 18 patients an outflow artery was demonstrated
at DSA, represented by the inferior mesenteric artery in 4
cases and by lumbar arteries in the remaining 5 patients.
At CTA, only 10 of 18 endoleaks were detected. In the
remaining 8 patients, the endoleak could not be visualized
in the arterial or in the venous scans. Endoleak volume,
calculated on venous scans, ranged from 0mL (no evidence
of endoleak) to 11.6 mL (mean  SD, 2.07  3.3 mL).
Analysis of endoleak features at CUS. Mean  SD
wash-in time was 122 132 seconds (median, 84 seconds;
range, 25 to 531 seconds); mean  SD washout time was
337  194 seconds (median, 320.5 seconds; range, 52 to
600 seconds); these two parameters were directly associ-
ated (P  .007, analysis of variance). An inflow lumbar
artery at CUS was detected in 6 patients; an outflow artery
was visualized in 6 patients; in 4 of these patients both
inflow and outflow arteries were visualized. Presence of
cavity filling was delineated in 7 cases.
Longer wash-in times were identified in patients with
lower cardiac ejection fractions; however, the difference
was not statistically significant (P  .08). Faster washout
time was significantly associated with the visualization of an
outflow artery at CUS (P .01, Student t test). Endoleaks
with washout time 520 seconds were associated with the
mic fe
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flow vessels at CUS and DSA (P  .05, 2test).
The amount of contrast material injected did not affect
the intra-arterial flow detection or any of the endoleak
dynamic features.
Analysis of endoleak detection at CTA. Endoleaks
missed at CTA showed longer wash-in and washout times
(mean  SD, 187.9  179.4 and 436.9  206.8 seconds,
respectively) compared with endoleaks visualized at CTA
Table II. CTA and DSA findings
Patient
no.
Time between
CTA exams
(mo)
AAA volume
(mL/mo)
1 8 1.19
2 4 2.1
3 6 0.23
4 4 2.62
5 8 0.36
6 3 1.37
7 6 0.67
8 6 2.48
9 12 0.46
10 5 2.24
11 12 0.33
12 6 1.66667
13 12 0.64
14 12 1.58
15 7 1.19
16 12 0.04
17 4 2.5
18 12 5.72
IMA, Inferior mesenteric artery.
*No relation between maximum diameter modifications and endoleak dyna
Table III. Findings at CUS
Patient
no.
Duration of
follow-up
(mo)*
Bolus
(mL)
Wash-in
(sec)
Dynamic
wash-in
1 21 1.5 40 Hyper
2 7 1.5 25 Hyper
3 18 1.5 50 Hyper
4 28 1.5 110 Hypo
5 46 1.5 36 Hyper
6 3 1.5 113 Hypo
7 24 1.5 28 Hyper
8 43 1.5 67 Hyper
9 31 1.5 40 Hyper
10 45 1.5 104 Hypo
11 36 1.5 220 Hypo
12 12 1.5 113 Hypo
13 41 2.4 34 Hyper
14 26 2.4 142 Hypo
15 24 2.4 73 Hyper
16 36 2.4 95 Hyper
17 55 2.4 531 Hypo
18 37 2.4 373 Hypo
Hyper, Hyperdynamic; Hypo, hypodynamic.
*Number of months between EVAR and CUS.(mean  SD, 69.1  35.1 and 257.5  147.4 seconds,respectively); the difference was statistically significant (P
.05, one-way analysis of variance and Student t test).
Presence of cavity filling at CUS seemed to allow en-
doleak visualization at CTA (Fig 1). In fact, all endoleaks
with cavity filling at CUS (n  7) were visualized at CTA,
whereas only 3 of 11 leaks with no cavity filling at CUS
could be depicted by CTA (P  .0006, 2test).
The presence of a detectable inflow at CUS was signif-
icantly associated with endoleak depiction at CTA (P 
AA
eter
/mo)*
Endoleak
volume
(mL)
Endoleak
detection
at CTA
Outflow
detection
at DSA
.54 1.6 Yes IMA
.82 6.6 Yes IMA
.22 0 No No
.07 8 Yes No
.14 0.8 Yes No
.5 0.2 Yes No
.38 3.5 Yes Lumbar
.38 1.75 Yes Lumbar
.08 0 No No
.46 2.5 Yes Lumbar
.21 0 No Lumbar
.17 0 No No
.13 0 No No
.36 0 No No
.54 11.6 Yes IMA
.12 1.7 Yes IMA
.37 0 No Lumbar
.37 0 No No
atures at CUS.
shout
ec)
Dynamic
washout
Inflow
visualization
Outflow
visualization
Cavity
filling
60 Hyper No No Yes
29 Hyper Yes Yes Yes
17 Hyper No No No
40 Hypo No No Yes
52 Hyper No No No
81 Hyper Yes No No
72 Hyper Yes Yes Yes
45 Hyper Yes Yes Yes
92 Hyper No No No
85 Hyper Yes Yes Yes
79 Hyper No Yes No
00 Hypo No No No
63 Hyper No No No
74 Hypo No No No
86 Hyper No Yes No
25 Hyper Yes No Yes
00 Hypo No No No
70 Hypo No No NoA
diam
(mm
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0Wa
(s
3
1
5
5
2
1
2
1
1
3
6
5
1
4
6
5.002, 2 test); all endoleaks with visualized inflow (n  6)
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January 200514 Bargellini et alFig 1. Patient 1, 78-year-old man with hyperdynamic endoleak. CTA shows a decrease in AAA volume at 20-month
follow-up (B) compared to the 12-month follow-up control (A), despite the evidence of a type II endoleak visualized
on the axial venous scans (C, arrow) fed by lumbar arteries (D, arrow). CUS shows the posterior endoleak (arrows)
characterized by the wash-in at 40 seconds (E), progressive cavity filling (F), and washout at 360 seconds; the contrast
material is no longer appreciated almost 10minutes after contrast material administration.Arrowheads indicate the time
(minutes and seconds) after injection of contrast material. At the top left corner, main parameters of CUS are indicated:
mechanical index (MI) and derated pressure (DP).
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inflow were visible at CTA.
Also the presence of an outflow at DSA seemed to
increase endoleak detectability at CTA; all endoleaks with
inferior mesenteric artery outflow and 3 of 4 cases with
lumbar outflowwere detected at CTA, whereas only 3 of 10
endoleaks without outflow were depicted at CTA (P .01,
2 test).
Analysis of AAA volume increase. Mean AAA volume
increase rate was 1.1  1.73 mL/mo (median, 0.654 mL/
mo; range,1.37 to 5.72mL/mo). An enlargement rate1
mL/mowas observed in 8 patients, whereas the remaining 10
patients exhibited volume changes1 mL/mo. In 3 patients
the aneurysm showed a progressive shrinkage despite the
presence of the endoleaks (Fig 1). The aneurysm size change
was not influenced by the duration of follow-up.
AAA enlargement 1 mL/mo was significantly more
frequent in AneuRx (Medtronic Inc, Minneapolis, Minn)
(4 of 6) and Excluder (W.L. Gore & Associates, Inc,
Newark, Del) (5 of 5) stent-grafts compared to the other
types of devices (P  .003, likelihood test).
The mean endoleak volume calculated at CTA did not
differ comparing patients with (2.6 3.1 mL) and without
(1.8  3.6 mL) significant volume enlargement.
Mean wash-in and washout times were shorter in pa-
tients with AAA enlargement rate 1 mL/mo (72.9 
58.9 and 262.7  155.5 seconds, respectively), compared
to patients with AAA enlargement 1 mL/mo (183.1 
174.7 and 430.4  205.3 seconds, respectively).
By Youden plots, the wash-in andwashout cutoff values
to identify significant AAA volume increase rate were 100
and 520 seconds, respectively (Figs 1 and 2). Times lower
than these referral values were used to define the endoleak
as hypodynamic.
According to the washout time, 5 endoleaks were de-
fined as hypodynamic and the remaining 13 as hyperdy-
namic. Sensitivity, specificity, PPV, NPV, and accuracy in
identifying significant enlarging AAAs were 62.5%, 100%,
100%, 76.9%, and 83.3%, respectively (P  .001). In fact,
all hypodynamic endoleaks showed significant enlarging
AAAs, together with three hyperdynamic endoleaks (pa-
tients 2, 8, and 10), whose washout times were 129, 245,
and 185 seconds, respectively.
According to the wash-in time, 10 endoleaks were
classified as hyperdynamic and 8 cases as hypodynamic; 3
cases showed fast washout with slow wash-in (patients 6,
10, and 11). Sensitivity, specificity, PPV, NPV, and accu-
racy in identifying enlarging AAAs were 75%, 80%, 75%,
80%, and 77.7%, respectively (P  .01); 2 hyperdynamic
endoleaks were associated with significant increase, and 2
hypodynamic endoleaks showed no significant AAA in-
crease.
According to the multiple logistic regression analysis,
the only independent predictor of AAA volume enlarge-
ment rate1mL/mowas the washout time520 seconds
(P  .009).DISCUSSION
Endoleaks represent the most frequent complication
after EVAR, occurring in up to 45% of patients, and can
determine aneurysm enlargement and increased pressuriza-
tion of the aneurysm sac, which require treatment to reduce
the risks of rupture.2,20 Endoleak classification has changed
over the years and currently distinguishes between en-
doleaks resulting in direct antegrade perfusion of the aneu-
rysm sac (types I, III, and IV) and endoleaks caused by
retrograde flow from aortic collateral vessels (type II).14,15
In addition, type V endoleaks have been introduced to
describe the continuous enlargement of an apparently ex-
cluded aneurysm, the so-called endotension.16,17,21,22
Type II endoleaks are reported to be far more frequent
than the other types2 and might represent a challenge in
terms of when and how to treat them.23,24 Recent studies
have demonstrated that they can be differentiated on the
basis of Doppler waveforms and flow velocities, affecting
endoleak persistence and treatment outcome.2,11,18,25
The purpose of our study was to investigate the ability
of CUS in differentiating type II lumbar endoleaks accord-
ing to specific CUS dynamic features and to identify a
possible correlation between this differentiation and the
rate of AAA enlargement. CUS has been proved to be a
useful tool in endoleak detection.13,26 According to our
experience, it provides the unique advantage of real-time
imaging, thus representing a valid and relatively easy
method in the analysis of endoleak dynamic behavior.
Our series included exclusively patients with CUS find-
ings suggestive for type II lumbar endoleaks that were
confirmed at DSA. By CUS, they showed different features
in terms of contrast enhancement and washout. According
to our data, these differences seem not to be related to the
endoleak extension or to the patient’s characteristics, such
as age and cardiac ejection fraction, that can affect systemic
cardiovascular conditions or to the amount of sonographic
contrast material injected, although the series is still lim-
ited, and only two different volumes of contrast were
tested. On the contrary, wash-in and washout times proved
to be mainly associated with the visualization of inflow and
outflow arteries. The absence of an outflow artery could
explain enhancement persistence and, therefore, what we
defined as a hypodynamic endoleak. Also, the lack of visu-
alization of the inflow at CUS was related to slow contrast
enhancement, probably because of the presence of tiny
lumbar arteries not detectable by CUS.
Hypodynamic endoleaks were also significantly related to
the lack of endoleak visualization at CTA. In fact, although
CTA still represents the preferred imaging modality in the
follow-up of aneurysm stent-grafts,6,7 several studies have
pointed out the presence of leaks that aremissed atCTA,2 and
alternative imaging tools have been proposed such as MRA,8
duplex US,27,28 and, lately, contrast-enhanced US.13 In a
recent study on patients with AAA enlargement and no evi-
dence of complications, CUS was able to identify the en-
doleak, thus arguing the existence of what has been defined as
endotension.26
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January 200516 Bargellini et alFig 2. Patient 14, 52-year-old man with hypodynamic endoleak. Compared to the 1-month CT control (A), the
12-month follow-up AAA volume shows a significant increase (B). However, no endoleak could be demonstrated at
CTA. CUS shows the absence of enhancement in the first minute scan after contrast material injection (C); a posterior
enhancement is appreciated more than 2 minutes after injection of contrast material (D, arrow), persisting for almost
10 minutes (E, arrow). Arrowheads indicate the time (minutes and seconds) after injection of contrast material. At the
top left corner, main parameters of CUS are indicated: mechanical index (MI) and derated pressure (DP).
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CTA were hypodynamic leaks. This association might con-
firm the hypothesis that the so-called endotensionmight be
represented by a very slow flow endoleak, not depictable
with standard imaging modalities.21 CTA visualization of
the endoleak was also related to the absence of inflow
arteries depicted at CUS (with slower wash-in time) and of
an outflow artery at CUS and DSA.
Finally, all endoleaks without what we called cavity
filling at CUS were missed at CTA. The spreading of the
contrast medium within the thrombus, without concentra-
tion in a defined region of the sac, could reduce CTA
detection capability; this limit could be overcome by MRA
and CUS8,9,13 by using blood pool contrast agents, which
could enhance flow detection.
To assess the role of dynamic features in the pressuriza-
tion of the aneurysm, we calculated aneurysm volume
defining a rate of increase per month. Volume assessment
has been proved to be more reliable and useful than maxi-
mum transverse diameters in the evaluation and manage-
ment of aneurysm enlargement.29-32 In our series, only
eight patients showed a rate of volume increase 1 mL/
mo, and three patients showed no enlargement at all,
despite the presence of the lumbar endoleak. This result
confirms previous findings, demonstrating the different
behavior of the leaks on aneurysm pressurization33,34 and
challenging physicians on when and how to treat lumbar
endoleaks,23,24 especially considering how difficult and
disappointing their treatment can be.35
Our data suggest that a volume increase 1 mL/mo
might be associated with hypodynamic type II leaks, par-
ticularly when considering a washout time 520 seconds.
Probably the hypodynamic endoleak is not able to create a
way out of the sac, thus causing aneurysm pressurization
and progressive enlargement,36,37 independently from
other factors such as endoleak volume and extension. On
the contrary, fast wash-in and washout could be interpreted
as rapid flow going through the sac without significant
effects on pressure and aneurysm increase; in these cases,
treatment could be avoided. Nevertheless, our hypothesis is
not supported by specific data, because intrasac pressures
were not measured. However, in a recent study on in vitro
aneurysm models, the absence of an outflow was associated
with increased mean sac pressure, similar to the mean aortic
pressure.38 This finding supports our data demonstrating
that the absence of an outflow, and therefore longer wash-
out times, is associated with higher enlargement rate caused
by higher intrasac pressure.
AAA enlargement rate was significantly different
among different types of stent-grafts. Devices such as Ex-
cluder and AneuRx seemed to be associated with a lower
enlargement rate, compared to the Talent stent-graft
(Medtronic Inc, Minneapolis, Minn).39 However, this re-
sult is biased by the limited number of patients and wide
range of devices in this series.
CUS represents a noninvasive, fast, well-tolerated, re-
producible, and apparently very sensitive imaging modali-
ty.12,13 In our experience the use of sonographic contrastagent tends to increase the sensitivity of the ultrasound
examination, overcoming some of its limitations and in-
creasing detectability of blood flow within the vessels with
no substantial need for complex maneuvers and no discom-
fort for the patient. However, the required equipment and
the contrast agent are highly specific and relatively expen-
sive, patient collaboration is needed, and the examination is
still operator dependent. Moreover, CUS seems not to be
appropriate for the evaluation of other parameters such as
graft anchorage and integrity and aneurysm morphologic
changes, for which CTA remains the first-option imaging
modality.40
The main limitation of our study is represented by the
low number of patients included. Larger series would be
required, possibly including a wider range of stent-grafts.
Moreover, because follow-up was inhomogeneous, a rate
of volume enlargement was used, and it was arbitrarly
considered significant when 1 mL/mo, on the basis of
the mean rate observed in our series (1.1 mL/mo); in fact,
to our knowledge, there are no available data regarding this
issue. However, we did not consider the interobserver
variability in volume measurements,29-32 which could bias
our results.
Finally, we were not able to demonstrate the role of our
findings in patient management, although we believe that
further confirmation of our results might influence treat-
ment planning of type II lumbar endoleak. In fact, because
type II lumbar endoleaks differ in terms of flow hemody-
namics and effects on the aneurysm sac, preprocedural
systematic embolization of the lumbar arteries would not
have a clinical rationale.41 Although the causes of these
differences are still unknown, our results point out the
usefulness of CUS to rapidly assess the type of lumbar
endoleak, identifying the wash-in and washout times, rec-
ognizing patients who might benefit from endoleak treat-
ment.
In conclusion, although larger series are required,
type II lumbar endoleaks show different hemodynamic
features at CUS, which might influence rate of aneurysm
enlargement, addressing the need for treatment. There-
fore, CUS might represent a valid tool in the decision
making and treatment planning of selected patients after
EVAR.
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